Instead of taking random tissue samples, physicians use an endoscope from which short bursts of light search areas suspected of having pre-cancerous cells. When the light hits the tissue, it scatters, and physicians can look for abnormalities to detect dysplasia.
The team has developed a technology called angle-resolved low coherence interferometry which shines light into a cell. Sensors capture and analyze the reflected light. The technology separates the patterns of the nucleus from other parts of the cell and can provide representations of shape changes.
In a clinical study, the system was 85 percent accurate when compared to pathological findings. The system was 86 percent accurate for pinpointing Barrett’s esophagus.
Related Articles about Colon Cancer:
40% of Medicare Cancer Screenings Are “Medically Unnecessary”
Women Can Wait Longer Than Men to Start Colonoscopies, Study Finds
Poll Finds Low Follow-up Screening Rates for Colon Cancer
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
